The Covid-19 Plasma Boom Is Over. What Did We Learn From It?
The U.S. government invested $800 million in plasma when the country was desperate for Covid-19 treatments. A year later, the program has fizzled.
The U.S. government invested $800 million in plasma when the country was desperate for Covid-19 treatments. A year later, the program has fizzled.
His testimony as an expert witness in some 600 trials helped plaintiffs win billions of dollars in cases involving malfeasance by pharmaceutical makers.
New regimens in development, including once-weekly pills and semiannual shots, could help control the virus in hard-to-reach populations.
In a first, the legislation extends privacy rights to the neural data increasingly coveted by technology companies.
In a first, the legislation extends privacy rights to the neural data increasingly coveted by technology companies.
Un grupo de científicos en Australia prueba distintas estrategias para proteger a uno de los animales más entrañables de su país.
Have your out-of-network insurance bills skyrocketed? Chris Hamby, an investigative reporter for The Times, may have an explanation.
The disaster, intensified by El Niño, is devastating communities across several countries, killing crops and livestock and sending food prices soaring.
New regimens in development, including once-weekly pills and semiannual shots, could help control the virus in hard-to-reach populations.
Ancient humans left behind numerous archaeological traces in the cavern, and scientists say there may be thousands more like it on the Arabian Peninsula to…
Have your out-of-network insurance bills skyrocketed? Chris Hamby, an investigative reporter for The Times, may have an explanation.